249 related articles for article (PubMed ID: 25867817)
41. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
Gajardo T; Morales RA; Campos-Mora M; Campos-Acuña J; Pino-Lagos K
Immunology; 2015 Sep; 146(1):81-8. PubMed ID: 25988395
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide.
Zang W; Lin M; Kalache S; Zhang N; Krüger B; Waaga-Gasser AM; Grimm M; Hancock W; Heeger P; Schröppel B; Murphy B
J Immunol; 2008 Dec; 181(11):7499-506. PubMed ID: 19017939
[TBL] [Abstract][Full Text] [Related]
43. Rapamycin Combined with Immature Dendritic Cells Attenuates Obliterative Bronchiolitis in Trachea Allograft Rats by Regulating the Balance of Regulatory and Effector T Cells.
Dong M; Wang X; Liu J; Zhao YX; Chen XL; Li KQ; Li G
Int Arch Allergy Immunol; 2015; 167(3):177-85. PubMed ID: 26302996
[TBL] [Abstract][Full Text] [Related]
44. Mesenchymal Stem Cells Overexpressing Interleukin-35 Propagate Immunosuppressive Effects in Mice.
Guo H; Zhao N; Gao H; He X
Scand J Immunol; 2017 Nov; 86(5):389-395. PubMed ID: 28888053
[TBL] [Abstract][Full Text] [Related]
45. Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice.
Sun YQ; Zhang Y; Li X; Deng MX; Gao WX; Yao Y; Chiu SM; Liang X; Gao F; Chan CW; Tse HF; Shi J; Fu QL; Lian Q
Stem Cells; 2015 Dec; 33(12):3452-67. PubMed ID: 26175298
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.
Yaochite JN; Caliari-Oliveira C; de Souza LE; Neto LS; Palma PV; Covas DT; Malmegrim KC; Voltarelli JC; Donadi EA
Stem Cell Res Ther; 2015 Mar; 6(1):31. PubMed ID: 25884215
[TBL] [Abstract][Full Text] [Related]
47. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
[TBL] [Abstract][Full Text] [Related]
48. Melatonin Synergizes With Mesenchymal Stromal Cells Attenuates Chronic Allograft Vasculopathy.
Qin YF; Kong DJ; Qin H; Zhu YL; Li GM; Sun CL; Zhao YM; Wang HD; Hao JP; Wang H
Front Immunol; 2021; 12():672849. PubMed ID: 33995416
[TBL] [Abstract][Full Text] [Related]
49. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
50. An immunotherapeutic strategy for prolonging graft survival in mice.
Wang F; Li J; Wang D; Fu Q; Xiong YY; Huang HT; Liu LS; Wang CX
Transpl Immunol; 2015 Oct; 33(2):84-94. PubMed ID: 26319678
[TBL] [Abstract][Full Text] [Related]
51. Mesenchymal stem cells home to inflamed ocular surface and suppress allosensitization in corneal transplantation.
Omoto M; Katikireddy KR; Rezazadeh A; Dohlman TH; Chauhan SK
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6631-8. PubMed ID: 25228546
[TBL] [Abstract][Full Text] [Related]
52. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
[TBL] [Abstract][Full Text] [Related]
53. Overexpression of galectin-9 in islets prolongs grafts survival via downregulation of Th1 responses.
Chou FC; Kuo CC; Wang YL; Lin MH; Linju Yen B; Chang DM; Sytwu HK
Cell Transplant; 2013; 22(11):2135-45. PubMed ID: 23067523
[TBL] [Abstract][Full Text] [Related]
54. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
55. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
56. CTLA4-Ig-modified dendritic cells inhibit lymphocyte-mediated alloimmune responses and prolong the islet graft survival in mice.
Yang DF; Qiu WH; Zhu HF; Lei P; Wen X; Dai H; Zhou W; Shen GX
Transpl Immunol; 2008 Jul; 19(3-4):197-201. PubMed ID: 18667318
[TBL] [Abstract][Full Text] [Related]
57. Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration.
Plain KM; Boyd R; Verma ND; Robinson CM; Tran GT; Hodgkinson SJ; Hall BM
Transplantation; 2007 Mar; 83(6):764-73. PubMed ID: 17414711
[TBL] [Abstract][Full Text] [Related]
58. sFgl2 gene-modified MSCs regulate the differentiation of CD4
Ji W; Wang W; Li P; Liu Y; Zhang B; Qi F
Stem Cell Res Ther; 2023 Nov; 14(1):316. PubMed ID: 37924141
[TBL] [Abstract][Full Text] [Related]
59. Ex vivo rapamycin generates Th1/Tc1 or Th2/Tc2 Effector T cells with enhanced in vivo function and differential sensitivity to post-transplant rapamycin therapy.
Jung U; Foley JE; Erdmann AA; Toda Y; Borenstein T; Mariotti J; Fowler DH
Biol Blood Marrow Transplant; 2006 Sep; 12(9):905-18. PubMed ID: 16920556
[TBL] [Abstract][Full Text] [Related]
60. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
